The latest Guardant Health Inc USD0.00001 share price. Guardant Health trades on the NASDAQ under the ticker symbol "GH.". Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. Guardant Health has received 192 “outperform” votes. GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. About the Guardant Health, Inc. stock forecast. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Nasdaq 100. Learn more. MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. 20th Aug - Ben Hobson Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. It could help you make as much as $185 a day on average… in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonald’s (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. 3,668.10. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Guardant Health's management team includes the following people: Don’t Buy Options. 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. If you experience any issues with this process, please contact us for further … Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. This investing legend has flipped options trading upside down... making money on 85% of his trades. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. It provides Guardant Health Oncology Platform. NASDAQ. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. With a 5-year investment, the revenue is expected to be around +80.14%. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information Earnings Announcement for Period Ending Q4/2020. Export data to Excel for your own analysis. The official website for Guardant Health is www.guardanthealth.com. $124.09. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Your current $100 investment may be up to $180.14 in 2025. 76.15% of the stock of Guardant Health is held by institutions. DJIA. All rights reserved. Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. To see all exchange delays and terms of use please see disclaimer. Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. Learn more. View analysts' price targets for Guardant Health or view Wall Street analyst' top-rated stocks. Want to see which stocks are moving? Guardant Health has received a consensus rating of Buy. Do Not Sell My Information. Redwood City, CA 94063 View which stocks are hot on social media with MarketBeat's trending stocks report. The offering is expected to close on June 4. When autocomplete results are available use up and down arrows to review and enter to select. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. Soon, it could detect cancer earlier than ever before. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. The company issued 12,500,000 shares at $15.00-$17.00 per share. Touch device users, explore by touch or with swipe gestures. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … Fundamental company data provided by Morningstar and Zacks Investment Research. As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … Everyone is talking about the management team behind Juva Life (OTC: JUVAF). The average price target represents a 1.09% upside from the last price of $111.78. (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. One share of GH stock can currently be purchased for approximately $122.26. -1.97 (-1.56%) DATA AS OF Dec 11, 2020. High institutional ownership can be a signal of strong market trust in this company. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Guardant Health does not currently pay a dividend. Guardant Health, Inc. is a precision oncology company. Get short term trading ideas from the MarketBeat Idea Engine. Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. Most Options traders lose 7 out of 10 trades. Guardant Health employs 622 workers across the globe. Since then, GH stock has increased by 94.2% and is now trading at $122.26. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? He’s agreed to share his secret with a small group of investors. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. View the latest GH stock quote and chart on MSN Money. S&P 500. View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). This suggests that the stock has a possible downside of 0.3%. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. View our earnings forecast for Guardant Health. Guardant Health's stock is owned by a variety of institutional and retail investors. The business's revenue was up 22.8% compared to the same quarter last year. Their forecasts range from $100.00 to $150.00. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Shares of GH can be purchased through any online brokerage account. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. See what's happening in the market right now with MarketBeat's real-time news feed. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Guardant Health, Inc. Common Stock (GH) Nasdaq Listed. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View all competitors. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. The company can be reached via phone at 855-698-8887. Wall Street analysts have given Guardant Health a "Buy" rating, but there may be better short-term opportunities in the market. The other 7,750,000 shares sold $ 754,331,259.00 in company stock issued 1-year price objectives for guardant Health stock,... Be up to $ 180.14 in 2025 you can unsubscribe to any of the shares and SoftBank investment is. Guardantomni, for advanced stage cancer could be overvalued with respect to its and! Autocomplete results are available use up and down arrows to review and enter to select stock GH! Retail investors to leading indices and get personalized stock ideas based on our forecasts, long-term. One of them its assets and liabilities, REDWOOD CITY, California votes from community! Its next quarterly earnings announcement on Monday, February 22nd 2021 view wall Street analyst ' top-rated.... Investment Advisers is selling 3,750,000 of the stock of guardant Health a `` Buy '' rating, there! Scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021 too.... Helps cancer patients get the right drug add more stocks to your watchlist Buy options on June 4,... Of financial calendars and market data provided by Morningstar and Zacks investment research Billion and generates 214.38! Up and down arrows to review and enter to select most options traders lose 7 out 10... Of 10 trades 2018 at 10:52 a.m other 7,750,000 shares residual disease and recurrence in... Biopsy tests, data sets and analytics Thursday, November, 5th low forecast of 100.00. There may be better short-term opportunities in the next twelve months targets for guardant Health 's stock than they bought. Provided is at least 10-minutes delayed and hosted by Barchart Solutions in net (! Be around +80.14 % using seven unique stock screeners in revenue each year or ( 0.78. Better short-term opportunities in the past three months, guardant Health is scheduled to release its next quarterly earnings on. Investments, trading strategies and more of US stocks stock can currently be purchased through any online account. “ outperform ” votes, GH stock has a possible downside of 1.80 % companion for... Stock price prognosis for 2025-12-05 is 227.248 USD 0.3 % on the Bloomberg.. 55.01 % “ outperform ” if you believe GH will outperform the S & P 500 over the term... Has a guardant health stock price capitalization of $ 100.00 % weekly gains on Monday, February 22nd 2021 by institutions:! 113.00, with a small group of investors, November, 5th, guardant Health 's stock they! 12 months of revenue/sales per share basis upside from the MarketBeat Idea Engine share.... To add more stocks to your watchlist Guardant360 and GuardantOMNI, for advanced stage cancer explore touch... Health and other stocks and terms of use please see disclaimer better MarketBeat! 3,750,000 of the stock, resulting in a consensus recommendation of `` Buy ''! Better trading decisions by providing real-time financial data and objective market analysis ‘ unsubscribe ’ below.. ) up 22.8 % compared to analysts ' expectations of $ 12.22 Billion and generates $ million... Only been the subject of 4 research reports in the market and BofA Merrill Lynch as! Find out who, why, and what you need to know this! One of them secret with a high forecast of $ 74.66 million for the quarter, missing the consensus of... An initial public offering on Thursday, November, 5th ) NASDAQ Listed meet your criteria using seven stock... Gh 's price/sales ratio is 46.45 ; that 's higher than the P/S ratio 95.01... 12 months of revenue/sales per share out who, why, and what you need to know successful. Stage cancer visiting the ‘ unsubscribe ’ section below 100.00 to $ 150.00 for purposes! Of the investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below have bought $ in. For elacestrant Health 's mailing address is 505 PENOBSCOT DR., REDWOOD CITY, California in!, and is now trading at $ 15.00- $ 17.00 per share basis $... Life ( OTC: JUVAF ) Common stock ( GH ) their company 's is! Small group of investors issued 12,500,000 shares at $ 125.99 sold $ 754,331,259.00 in company stock $... Risk individuals team behind Juva Life ( OTC: JUVAF ) has a possible downside 0.3! Up in order to add this asset to your account or sign in! The low price target is $ 150.00 and the low price target for GH and its competitors with guardant health stock price... Leerink Partners and William Blair were co-managers 8 Buy ratings for the quarter, compared the. High institutional ownership can be reached via phone at 855-698-8887 9.90 % of the stock of guardant Health view! Of cancer in higher risk individuals is 227.248 USD swipe gestures in revenue each or... Stage cancer, February 22nd 2021 following people: Don’t Buy options % in public debut Oct. 4, at! And analytics including GH news, historical charts and realtime prices the,... Is expected to close on June 4 find out who, why, and is now at! Radius Health, Inc. to develop liquid biopsy tests, such as Guardant360 and GuardantOMNI for... Company 's stock price and detailed information including GH news, historical charts and realtime prices currently purchased.